Clinical Trial Update: A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for 6MW3211 in AML and MDS across Phase 1 and Phase 2

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• 6MW3211

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: UNKNOWN